Neotract
About:
NeoTract develops surgical devices for urological and gynecological disorders.
Twitter/X: neotract
Top Investors: New Enterprise Associates, ExploraMed, Greenspring Associates, Quadrille Capital, Windham Venture Partners
Description:
NeoTract, Inc. develops surgical devices for urological and gynecological disorders.
Total Funding Amount:
$176M
Estimated Revenue Range:
$100M to $500M
Headquarters Location:
Mountain View, California, United States
Founded Date:
2004-01-01
Founders:
Joseph Catanese, Josh Makower, Ted Lamson
Number of Employees:
251-500
Last Funding Date:
2017-01-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai